Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Mod Pathol ; 33(12): 2507-2519, 2020 12.
Article in English | MEDLINE | ID: mdl-32591586

ABSTRACT

The precise nature of the local immune responses in lung tuberculosis (TB) granulomas requires a comprehensive understanding of their environmental complexities. At its most basic level, a granuloma is a compact, organized immune aggregate of macrophages surrounded by myeloid, B and T cells. We established two complementary multiplex immunolabeling panels to simultaneously evaluate the myeloid and lymphocytic contexture of 14 human lung TB granulomas in formalin-fixed paraffin-embedded tissue samples. We observed diverse CD3+ and CD8+ T-cell and CD20+ B lymphocyte compositions of the granuloma immune environment and a relatively homogeneous distribution of all myeloid cells. We also found significant associations between CD8+ T-cell densities and the myeloid marker CD11b and phagocytic cell marker CD68. In addition, significantly more CD68+ macrophages and CD8+ T cells were found in Mycobacterium tuberculosis-infected granulomas, as detected by Ziehl-Neelsen staining. FOXP3 expression was predominately found in a small subset of CD4+ T cells in different granulomas. As the success or failure of each granuloma is determined by the immune response within that granuloma at a local and not a systemic level, we attempted to identify the presence of reactive T cells based on expression of the T-cell activation marker CD137 (4-1BB) and programmed cell death-1 (PD-1). Only a small fraction of the CD4+ and CD8+ T cells expressed PD-1. CD137 expression was found only in a very small fraction of the CD4+ T cells in two granulomas. Our results also showed that multinucleated giant cells showed strong PD-L1 but not CTLA-4 membrane staining. This study offers new insights into the heterogeneity of immune cell infiltration in lung TB granulomas, suggesting that each TB granuloma represents a unique immune environment that might be independently influenced by the local adaptive immune response, bacterial state, and overall host disease status.


Subject(s)
Adaptive Immunity , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cellular Microenvironment/immunology , Fluorescent Antibody Technique , Granuloma/immunology , Immunophenotyping , Lung/immunology , Mycobacterium tuberculosis/immunology , Myeloid Cells/immunology , Tuberculosis, Pulmonary/immunology , Adult , Aged , Biomarkers/analysis , Granuloma/microbiology , Host-Pathogen Interactions , Humans , Lung/microbiology , Male , Microscopy, Fluorescence , Middle Aged , Phenotype , Tuberculosis, Pulmonary/microbiology , Young Adult
2.
Pediatr Dermatol ; 37(4): 750-751, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32239709

ABSTRACT

Unilateral linear capillaritis is a rare variant of the pigmented purpuric dermatoses that can be misdiagnosed due to confusion with other cutaneous diseases that follow a linear distribution. We present the case of an 8-year-old boy with hyperpigmented patches linearly distributed on the right arm, initially diagnosed with segmental neurofibromatosis.


Subject(s)
Pigmentation Disorders , Purpura , Skin Diseases, Vascular , Skin Diseases , Capillaries , Child , Humans , Male
3.
Pediatr Dermatol ; 36(6): 980-981, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31468559

ABSTRACT

Granulomatous periorificial dermatitis is a clinical variant of periorificial dermatitis. We present the case of an 18-year-old girl with several reddish papular lesions in the perioral, perinasal, and periorbital regions unresponsive to conventional therapy. After 6 months of therapy with low-dose oral isotretinoin, the lesions fully remitted.


Subject(s)
Dermatitis, Perioral/drug therapy , Dermatologic Agents/therapeutic use , Granuloma/drug therapy , Isotretinoin/therapeutic use , Administration, Oral , Adolescent , Dermatitis, Perioral/pathology , Dose-Response Relationship, Drug , Female , Granuloma/pathology , Humans
4.
J Transl Med ; 15(1): 104, 2017 05 12.
Article in English | MEDLINE | ID: mdl-28499389

ABSTRACT

BACKGROUND: Prognosis of patients with glioblastoma multiforme (GBM) remains dismal, with median overall survival (OS) of about 15 months. It is therefore crucial to search alternative strategies that improve these results obtained with conventional treatments. In this context, immunotherapy seems to be a promising therapeutic option. We hypothesized that the addition of tumor lysate-pulsed autologous dendritic cells (DCs) vaccination to maximal safe resection followed by radiotherapy and concomitant and adjuvant temozolomide could improve patients' survival. METHODS: We conducted a phase-II clinical trial of autologous DCs vaccination in patients with newly diagnosed patients GBM who were candidates to complete or near complete resection. Candidates were finally included if residual tumor volume was lower than 1 cc on postoperative radiological examination. Autologous DCs were generated from peripheral blood monocytes and pulsed with autologous whole tumor lysate. The vaccination calendar started before radiotherapy and was continued during adjuvant chemotherapy. Progression free survival (PFS) and OS were analyzed with the Kaplan-Meier method. Immune response were assessed in blood samples obtained before each vaccines. RESULTS: Thirty-two consecutive patients were screened, one of which was a screening failure due to insufficient resection. Median age was 61 years (range 42-70). Karnofsky performance score (KPS) was 90-100 in 29%, 80 in 35.5% and 60-70 in 35.5% of cases. MGMT (O6-methylguanine-DNA-methyltransferase) promoter was methylated in 45.2% of patients. No severe adverse effects related to immunotherapy were registered. Median PFS was 12.7 months (CI 95% 7-16) and median OS was 23.4 months (95% CI 16-33.1). Increase in post-vaccination tumor specific immune response after vaccines (proliferation or cytokine production) was detected in 11/27 evaluated patients. No correlation between immune response and survival was found. CONCLUSIONS: Our results suggest that the addition of tumor lysate-pulsed autologous DCs vaccination to tumor resection and combined radio-chemotherapy is feasible and safe. A multicenter randomized clinical trial is warranted to evaluate the potential survival benefit of this therapeutic approach. Trial registration This phase-II trial was registered as EudraCT: 2009-009879-35 and ClinicalTrials.gov Identifier: NCT01006044 retrospectively registered.


Subject(s)
Brain Neoplasms/immunology , Brain Neoplasms/therapy , Chemoradiotherapy , Dendritic Cells/immunology , Glioblastoma/immunology , Glioblastoma/therapy , Vaccination , Adult , Aged , Brain Neoplasms/blood , Brain Neoplasms/surgery , Chemoradiotherapy/adverse effects , Combined Modality Therapy , Cytokines/blood , Disease-Free Survival , Feasibility Studies , Female , Fluorescence , Glioblastoma/blood , Glioblastoma/surgery , Humans , Inflammation/pathology , Male , Middle Aged , Survival Analysis , Transplantation, Autologous , Vaccination/adverse effects
5.
Transpl Int ; 29(9): 1008-16, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27208691

ABSTRACT

Kaposi's sarcoma (KS) is one of the most frequent transplant related tumors. Several pathways are involved; however, the impact of the molecular phenotype associated to the tumor stage and the behavior-depending resultant therapy is still unknown. The aim of our study was to analyze the role of HHV-8 and mTOR pathway in tumor stages of skin KS after renal transplantation. Twelve renal transplant recipients with cutaneous KS from five transplant centers (1980-2007) under reduction of immunosuppression or conversion to mTOR inhibitor were included. The expression of HHV-8, PTEN, TGFß, VEGF, phospho-mTOR, and phospho-P70S6K in tumoral tissue was analyzed. KS lesions were classified as patch, plaque, and nodule state. HHV-8 infection was found in all tissue samples. KS lesions showed high activation of VEGF, p-mTOR and p-P70S6K, low PTEN, and null TGFß expression. The only pathway activated in a staging-dependent manner was mTOR with higher p-mTOR and p-P70S6K expression in nodule versus patch stage. KS lesions disappeared after 5.24 months in all converted patients without any recurrence in 14.05 years of mean follow-up. The activation of mTOR pathway according to KS stages supports the rational of the mTOR inhibitor in post-transplant Kaposi.


Subject(s)
Kidney Transplantation , Neoplasm Staging/methods , Sarcoma, Kaposi/metabolism , TOR Serine-Threonine Kinases/metabolism , Aged , Female , Graft Survival , Herpesvirus 8, Human , Humans , Immunosuppression Therapy , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Multivariate Analysis , Neoplasm Recurrence, Local , PTEN Phosphohydrolase/metabolism , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Sarcoma, Kaposi/virology , Spain , Time Factors , Transforming Growth Factor beta/metabolism , Vascular Endothelial Growth Factor A/metabolism
10.
J Cosmet Laser Ther ; 16(3): 141-3, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24131099

ABSTRACT

Fox Fordyce disease (FFD) has been recently described as an adverse effect of laser hair removal. It is an apocrine gland disorder characterized by pruritus and a folliculocentric papular eruption in apocrine sweat gland areas. Different etiologies have been proposed to be the cause of this entity. It has been suggested that a fisical factor could contribute to FFD phatogenesis. We report a new case of FFD after laser hair removal.


Subject(s)
Axilla , Fox-Fordyce Disease/etiology , Hair Removal/adverse effects , Lasers, Semiconductor/adverse effects , Low-Level Light Therapy/adverse effects , Adult , Female , Humans , Pruritus/etiology
11.
Headache ; 53(6): 994-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23469985

ABSTRACT

Cephalalgia alopecia is a rare and recently described headache syndrome in which recurrent, burning head and neck pain is associated with hair loss from areas of scalp affected by the pain. We here report the case of a 33-year-old woman with continuous unilateral occipital pain and colocalized alopecia, only responsive to onabotulinumtoxin A injections. We hypothesize whether this clinical phenotype may correspond to either cephalalgia alopecia or nummular headache with trophic changes, conditions that might represent 2 manifestations of the same spectrum of disorders.


Subject(s)
Alopecia/complications , Alopecia/diagnosis , Headache/complications , Headache/diagnosis , Neck Pain/complications , Neck Pain/diagnosis , Adult , Alopecia/drug therapy , Botulinum Toxins, Type A/administration & dosage , Female , Follow-Up Studies , Headache/drug therapy , Humans , Neck Pain/drug therapy
16.
Neurocirugia (Astur) ; 24(2): 78-81, 2013.
Article in Spanish | MEDLINE | ID: mdl-23177734

ABSTRACT

INTRODUCTION: Muir-Torre syndrome is a genetic disease characterised by the association of sebaceous neoplasms with visceral neoplasms, mainly colorectal cancer and secondly urogenital tumours. Metastases from prostate tumours without systemic disease are rare in the brain and exceptional in the brainstem. CASE REPORT: We present a 48-year old male, with a single brainstem metastasis from a prostate adenocarcinoma, who had previously been diagnosed with Muir-Torre syndrome. Diagnostic stereotactic biopsy was performed. CONCLUSION: Single metastasis from a prostate adenocarcinoma in the brainstem without systemic disease is exceptional. Due to the different diagnostic possibilities, biopsy should be performed in order to obtain a diagnosis, especially in the context of Muir-Torre syndrome.


Subject(s)
Adenocarcinoma/secondary , Biopsy , Brain Stem Neoplasms/secondary , Muir-Torre Syndrome , Prostatic Neoplasms/pathology , Adenocarcinoma/diagnosis , Adenocarcinoma/genetics , Adenocarcinoma/therapy , Adenoma/genetics , Anilides/administration & dosage , Anilides/therapeutic use , Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Agents, Hormonal/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Stem Neoplasms/diagnosis , Brain Stem Neoplasms/genetics , Combined Modality Therapy , Docetaxel , Humans , Male , Middle Aged , Muir-Torre Syndrome/genetics , MutS Homolog 2 Protein/deficiency , MutS Homolog 2 Protein/genetics , Mutation , Neoplasms, Multiple Primary/genetics , Neuronavigation/methods , Nitriles/administration & dosage , Nitriles/therapeutic use , Prostatectomy , Prostatic Neoplasms/genetics , Prostatic Neoplasms/therapy , Radiotherapy, Adjuvant , Rectal Neoplasms/genetics , Sigmoid Neoplasms/genetics , Taxoids/administration & dosage , Tosyl Compounds/administration & dosage , Tosyl Compounds/therapeutic use
17.
Gynecol Obstet Invest ; 73(4): 265-71, 2012.
Article in English | MEDLINE | ID: mdl-22538201

ABSTRACT

The diagnosis rate of deep pelvic endometriosis is increasing. Endometrial stromal sarcoma (ESS) is a rare neoplasm. Extragenital ESS is an extremely uncommon event. Very few cases of extragenital ESS have been reported to date. The diagnosis of this entity is very difficult in some instances. Knowledge about its management is also limited. In this paper, we review the current literature on the clinical management, histology, immunohistochemistry, treatment and outcome of ESS arising in pelvic endometriosis.


Subject(s)
Cell Transformation, Neoplastic/pathology , Endometriosis/pathology , Sarcoma, Endometrial Stromal/diagnosis , Adult , Aged , Female , Humans , Immunohistochemistry , MEDLINE , Middle Aged , Peritoneal Neoplasms/diagnosis , Peritoneal Neoplasms/pathology , Peritoneal Neoplasms/surgery , Prognosis , Rectal Neoplasms/pathology , Rectal Neoplasms/surgery , Sarcoma, Endometrial Stromal/pathology , Sarcoma, Endometrial Stromal/surgery , Ultrasonography , Vaginal Neoplasms/pathology , Vaginal Neoplasms/surgery
18.
Rev Esp Enferm Dig ; 104(4): 214-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22537372

ABSTRACT

Herpetic esophagitis in immunocompetent individuals is a rare entity that should be suspected clinically by an acute onset of symptoms, and without apparent cause of a symptomatic triad consisting on odynophagia, heartburn and fever. Its occurrence may be due to reactivation of a previous infection or less often a primary infection. Herpes simplex type 1 is the most common cause. Upper endoscopy establishes the diagnosis of suspicion of herpetic esophagitis. It also allows to take multiple biopsy samples and viral culture, leading to a definitive diagnosis. The severity of symptoms is related to the degree of oesophageal involvement. In immunocompromised patients treatment is indicated with acyclovir, but the indication in immunocompetent patients is controversial because the process is time, limited with a low probability of complications. We present a case of acute herpetic esophagitis in an immunocompetent host that debuted acutely with severe upper gastrointestinal tract symptoms, associated with an insidious and nonspecific onset of flu-like symptoms. Endoscopic findings showed a severe involvement in the lower third of the oesophageal mucosa.


Subject(s)
Esophagitis/virology , Herpes Simplex/diagnosis , Adolescent , Esophagitis/diagnosis , Humans , Immunocompetence , Male
19.
Rev Esp Patol ; 55(3): 192-196, 2022.
Article in Spanish | MEDLINE | ID: mdl-35779886

ABSTRACT

A 54-year-old female patient presented with a left nasal obstruction. On physical examination a pink delimited mass in the left nostril was observed. A cranial computed tomography scan revealed an expansive mass in the upper anterior third of the left nasal fossa, partially obstructing it. Endoscopic resection of the mass was performed. Histopathology revealed an atypical mesenchymal proliferation formed by cells disposed in disorganized and interconnected long bundles. Tumor cells had abundant eosinophilic cytoplasm and an oval, vesicular and hyperchromatic nucleus. Frequent mitotic figures were observed, many of them atypical. Necrosis was not observed. Immunohistochemistry showed tumor cells to be positive for calponin, muscle specific actin, caldesmon and smooth muscle specific myosin. Ki-67 index proliferation was 30%. A diagnosis of leiomyosarcoma of the nasal fossa was established.


Subject(s)
Leiomyosarcoma , Actins , Cell Nucleus/pathology , Female , Humans , Immunohistochemistry , Leiomyosarcoma/pathology , Middle Aged , Tomography, X-Ray Computed
20.
J Ultrasound ; 25(2): 289-295, 2022 Jun.
Article in English | MEDLINE | ID: mdl-33453055

ABSTRACT

PURPOSE: Diagnosis of granuloma annulare (GA) is based on the clinical and histopathological findings. However, only sporadic case reports of subcutaneous GA sonography have been published to date. The objective of this study was to evaluate the ultrasonographic patterns of the different clinical variants of GA: localized, generalized, subcutaneous, and perforating. METHODS: In this retrospective observational study, we analyzed and correlated the clinical, histopathological, and sonographic features of 15 patients diagnosed with GA. RESULTS: We included 8 women and 7 men with a mean age of 48.4 years (8-77 years). We found three different sonographic patterns depending on the clinical variant of GA: poorly defined hypoechoic band including the dermis (dermal pattern), irregularly shaped hypoechoic hypodermal lumps (hypodermal pattern), and ill-defined hypoechoic dermal and subcutaneous lesions (mixed pattern). Five cases showed increased blood flow signal on Doppler interrogation. CONCLUSION: Although our findings are broadly consistent with the previous reports of subcutaneous GA, the sonographic features in localized, generalized, and perforating GA have not been previously reported.


Subject(s)
Granuloma Annulare , Female , Granuloma Annulare/diagnostic imaging , Granuloma Annulare/etiology , Humans , Male , Middle Aged , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL